We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.95%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.8B
AUM Growth
-$8.26B
(-8%)
Cap. Flow
-$2.48B
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
21.55%
Holding
2,181
New
100
Increased
1,075
Reduced
690
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$671M |
| 2 |
Broadcom
AVGO
|
+$416M |
| 3 |
ServiceNow
NOW
|
+$264M |
| 4 |
Arista Networks
ANET
|
+$262M |
| 5 |
Autodesk
ADSK
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$284M |
| 2 |
Microsoft
MSFT
|
+$281M |
| 3 |
Micron Technology
MU
|
+$275M |
| 4 |
Teradyne
TER
|
+$274M |
| 5 |
KLA
KLAC
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.64% |
| 2 | Industrials | 14.32% |
| 3 | Healthcare | 12.96% |
| 4 | Financials | 7.97% |
| 5 | Utilities | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Datadog
DDOG
$88.6B
| $74.9M | 0.08% |
634,338
+2,621
| +0.4% | +$324K |
|
|
MRSH
252
Marsh
MRSH
$91.3B
| $74.6M | 0.08% |
430,325
+11,364
| +3% | +$2.04M |
|
253
Roivant Sciences
ROIV
$25.5B
| $74M | 0.08% |
2,673,233
+360,797
| +16% | +$9.27M |
|
254
Casella Waste Systems
CWST
$5.89B
| $73.3M | 0.08% |
924,375
-66,276
| -7% | -$6.35M |
|
255
NRG Energy
NRG
$25.2B
| $73.3M | 0.08% |
501,766
+76,711
| +18% | +$12.1M |
|
256
Nike
NKE
$61.3B
| $73.2M | 0.08% |
1,386,091
-337,600
| -20% | -$20.5M |
|
257
O'Reilly Automotive
ORLY
$74.9B
| $73.1M | 0.08% |
792,359
+43,163
| +6% | +$4.05M |
|
258
Agnico Eagle Mines
AEM
$92B
| $73.1M | 0.08% |
361,794
+874
| +0.2% | +$182K |
|
259
Axsome Therapeutics
AXSM
$11.1B
| $70.3M | 0.07% |
415,983
-20,080
| -5% | -$3.47M |
|
260
Estee Lauder
EL
$31.8B
| $69.9M | 0.07% |
973,478
+124,079
| +15% | +$12.7M |
|
261
Packaging Corp of America
PKG
$22.9B
| $69.7M | 0.07% |
328,650
-11,401
| -3% | -$2.54M |
|
262
Progressive
PGR
$123B
| $68.9M | 0.07% |
347,477
+10,605
| +3% | +$2.19M |
|
263
Allstate
ALL
$66.3B
| $68.8M | 0.07% |
332,049
-55,226
| -14% | -$11.3M |
|
264
Cogent Biosciences
COGT
$6.61B
| $68.8M | 0.07% |
1,798,768
+1,686,292
| +1,499% | +$62.3M |
|
265
Crinetics Pharmaceuticals
CRNX
$8.95B
| $68.2M | 0.07% |
1,884,281
+323,981
| +21% | +$14.5M |
|
266
American Tower
AMT
$79B
| $67.7M | 0.07% |
392,261
-10,437
| -3% | -$1.88M |
|
267
BioMarin Pharmaceuticals
BMRN
$13.5B
| $67.1M | 0.07% |
1,193,661
-89,961
| -7% | -$5.25M |
|
268
Varonis Systems
VRNS
$4.84B
| $67M | 0.07% |
3,123,056
+944,676
| +43% | +$25.6M |
|
|
BNY
269
Bank of New York Mellon
BNY
$109B
| $66M | 0.07% |
556,999
+44,888
| +9% | +$5.34M |
|
|
MDLN
270
Medline Inc
MDLN
$30.7B
| $64.9M | 0.07% |
1,458,011
+291,438
| +25% | +$12.9M |
|
271
Nu Holdings
NU
$65.9B
| $64.6M | 0.07% |
4,495,568
-250,368
| -5% | -$4.06M |
|
272
Deutsche Bank
DB
$71.8B
| $63.9M | 0.07% |
2,209,846
+630,894
| +40% | +$22.2M |
|
273
Modine Manufacturing
MOD
$10.5B
| $61.6M | 0.07% |
284,431
-37,446
| -12% | -$7.05M |
|
274
Protagonist Therapeutics
PTGX
$9.6B
| $61.2M | 0.06% |
581,083
+51,452
| +10% | +$4.56M |
|
275
Dell
DELL
$285B
| $61.1M | 0.06% |
372,240
-61,485
| -14% | -$8.19M |
|
Similar funds
Pictet Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Pictet Asset Management held 2,181 positions worth $94.8B, down 8% from $103B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Pictet Asset Management's Q1 2026 filing shows 100 new, 1,075 increased, 690 reduced and 79 closed positions. Its largest new stake was AstraZeneca: 3,481,864 shares worth $675M. The largest sale was Lam Research, an estimated $284M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2026 buy was AstraZeneca: 3,481,864 shares worth $675M.
- Pictet Asset Management added most to Broadcom in Q1 2026, an estimated $416M increase.
- Pictet Asset Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
- Pictet Asset Management fully exited CyberArk in Q1 2026, selling an estimated $104M.
- Pictet Asset Management's ten largest holdings make up 22% of its $94.8B portfolio in Q1 2026.
- Pictet Asset Management opened 100 new positions and closed 79 in Q1 2026.
- Pictet Asset Management's portfolio value fell 8% quarter-over-quarter to $94.8B.
Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.